BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23796688)

  • 1. Screening and characterization of reactive compounds with in vitro peptide-trapping and liquid chromatography/high-resolution accurate mass spectrometry.
    Wei C; Chupak LS; Philip T; Johnson BM; Gentles R; Drexler DM
    J Biomol Screen; 2014 Feb; 19(2):297-307. PubMed ID: 23796688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Improved detection of reactive metabolites with a bromine-containing glutathione analog using mass defect and isotope pattern matching.
    Leblanc A; Shiao TC; Roy R; Sleno L
    Rapid Commun Mass Spectrom; 2010 May; 24(9):1241-50. PubMed ID: 20391594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of LC-high-resolution MS with 'intelligent' data mining tools for screening reactive drug metabolites.
    Ma S; Chowdhury SK
    Bioanalysis; 2012 Mar; 4(5):501-10. PubMed ID: 22409549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution chromatography/time-of-flight MSE with in silico data mining is an information-rich approach to reactive metabolite screening.
    Barbara JE; Castro-Perez JM
    Rapid Commun Mass Spectrom; 2011 Oct; 25(20):3029-40. PubMed ID: 21953957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid detection and characterization of reactive drug metabolites in vitro using several isotope-labeled trapping agents and ultra-performance liquid chromatography/time-of-flight mass spectrometry.
    Rousu T; Pelkonen O; Tolonen A
    Rapid Commun Mass Spectrom; 2009 Mar; 23(6):843-55. PubMed ID: 19224530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of peptide substrate and small molecule inhibitors of testis-specific serine/threonine kinase1 (TSSK1) by the developed assays.
    Zhang L; Yan Y; Liu Z; Abliz Z; Liu G
    J Med Chem; 2009 Jul; 52(14):4419-28. PubMed ID: 19530700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-throughput liquid chromatography/mass spectrometry method for the quantitation of small molecules using accurate mass technologies in supporting discovery drug screening.
    Ding X; Ghobarah H; Zhang X; Jaochico A; Liu X; Deshmukh G; Liederer BM; Hop CE; Dean B
    Rapid Commun Mass Spectrom; 2013 Feb; 27(3):401-8. PubMed ID: 23280971
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution MS in regulated bioanalysis: where are we now and where do we go from here?
    Fung EN; Jemal M; Aubry AF
    Bioanalysis; 2013 May; 5(10):1277-84. PubMed ID: 23721448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of CYP102A1M11H as a tool for the generation of protein adducts of reactive drug metabolites.
    Boerma JS; Vermeulen NP; Commandeur JN
    Chem Res Toxicol; 2011 Aug; 24(8):1263-74. PubMed ID: 21639118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glutathione S-transferase pi trapping method for generation and characterization of drug-protein adducts in human liver microsomes using liquid chromatography-tandem mass spectrometry.
    Yukinaga H; Iwabuchi H; Okazaki O; Izumi T
    J Pharm Biomed Anal; 2012; 67-68():186-92. PubMed ID: 22608530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative structure-retention relationships models for prediction of high performance liquid chromatography retention time of small molecules: endogenous metabolites and banned compounds.
    Goryński K; Bojko B; Nowaczyk A; Buciński A; Pawliszyn J; Kaliszan R
    Anal Chim Acta; 2013 Oct; 797():13-9. PubMed ID: 24050665
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel approach for predicting acyl glucuronide reactivity via Schiff base formation: development of rapidly formed peptide adducts for LC/MS/MS measurements.
    Wang J; Davis M; Li F; Azam F; Scatina J; Talaat R
    Chem Res Toxicol; 2004 Sep; 17(9):1206-16. PubMed ID: 15377154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a new screening method for the detection of antibiotic residues in muscle tissues using liquid chromatography and high resolution mass spectrometry with a LC-LTQ-Orbitrap instrument.
    Hurtaud-Pessel D; Jagadeshwar-Reddy T; Verdon E
    Food Addit Contam Part A Chem Anal Control Expo Risk Assess; 2011 Oct; 28(10):1340-51. PubMed ID: 22007888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of liquid chromatography-high-resolution mass spectrometry (LC-HR/MS) in clinical toxicology.
    Wu AH; Gerona R; Armenian P; French D; Petrie M; Lynch KL
    Clin Toxicol (Phila); 2012 Sep; 50(8):733-42. PubMed ID: 22888997
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Covalent adduction of nitrogen mustards to model protein nucleophiles.
    Thompson VR; DeCaprio AP
    Chem Res Toxicol; 2013 Aug; 26(8):1263-71. PubMed ID: 23859065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A semiquantitative method for the determination of reactive metabolite conjugate levels in vitro utilizing liquid chromatography-tandem mass spectrometry and novel quaternary ammonium glutathione analogues.
    Soglia JR; Contillo LG; Kalgutkar AS; Zhao S; Hop CE; Boyd JG; Cole MJ
    Chem Res Toxicol; 2006 Mar; 19(3):480-90. PubMed ID: 16544956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-throughput fragment screening by affinity LC-MS.
    Duong-Thi MD; Bergström M; Fex T; Isaksson R; Ohlson S
    J Biomol Screen; 2013 Feb; 18(2):160-71. PubMed ID: 22983162
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of laser diode thermal desorption (LDTD) coupled with tandem mass spectrometry (MS/MS) for support of in vitro drug discovery assays: increasing scope, robustness and throughput of the LDTD technique for use with chemically diverse compound libraries.
    Beattie I; Smith A; Weston DJ; White P; Szwandt S; Sealey L
    J Pharm Biomed Anal; 2012 Feb; 59():18-28. PubMed ID: 22071442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 16α-Hydroxyestrone: Mass Spectrometry-Based Methodologies for the Identification of Covalent Adducts Formed with Blood Proteins.
    Charneira C; Nunes J; Antunes AMM
    Chem Res Toxicol; 2020 Aug; 33(8):2147-2156. PubMed ID: 32692160
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of modification sites on human serum albumin and human hemoglobin adducts with houttuynin using liquid chromatography coupled with mass spectrometry.
    Deng Z; Zhong D; Chen X
    Biomed Chromatogr; 2012 Nov; 26(11):1377-85. PubMed ID: 22334394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.